The governmental advisory panel tasked with issuing cancer screening guidelines made a final recommendation on the most common form of prostate cancer screening, PSA tests. Jacques Carter, HMS assistant professor of medicine at Beth Israel Deaconess Medical Center, is quoted.
The Wyss Institute for Biologically Inspired Engineering at Harvard accepted a Webby Award yesterday. The institute won the award, which recognizes the best of the Internet, in the science category.
Julie Silver, HMS assistant professor of physical medicine and rehabilitation at Spaulding Rehabilitation Hospital, believes that the 12 million cancer survivors in the United States should have rehabilitation services provided as a standard part of cancer care.
Earlier in May, the China-Harvard Medical School Translational Medicine Consortium MOU Signing Ceremony was held at Shanghai International Convention Center. William Chin, executive dean for research;David Golan, dean for graduate education and Lee Nadler, dean for clinical and translational research at HMS, were present for the ceremony.
The drug Zytiga, approved last year to treat metastatic prostate cancer, helped eliminate tumors in high-risk patients whose malignancy hadn’t yet spread, a small study found. Mary-Ellen Taplin, HMS associate professor of medicine at Dana Farber Cancer Institute, was the leader of the study.
A 29-item checklist dramatically increased the frequency with which providers in an Indian hospital took simple steps to protect the health of women in childbirth and their babies, such as washing their handswith soap before an exam or using a sterile blade to cut the umbilical cord. Atul Gawande, HMS associate professor of surgery at Brigham and Women’s Hospital and Jonathan Spector, HMS instructor in pediatrics at Massachusetts General Hospital, led the study.